London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Short-term effects of intravitreal ranibizumab on lens clarity: a lens densitometry study

Poster Details

First Author: M.Sekeroglu TURKEY

Co Author(s):    M. Anayol   B. Bostanci Ceran   P. Yilmazbas        

Abstract Details

Purpose:

To evaluate the short-term effects of single intravitreal ranibizumab injection on the density of lens nucleus.

Setting:

Ulucanlar Eye Training and Research Hospital, Ankara, Turkey

Methods:

The lens nucleus density of the patients with diabetic macular edema who underwent a single intravitreal ranibizumab injection were measured by corneal topography (Pentacam HR, Oculus, Inc., Wetzler, Germany) before and one month after the injection. The patients with a previous history of ocular surgery, laser photocoagulation and/or intravitreal injection were all excluded.

Results:

Forty-three eyes of 25 treatment-naive patients (16 males, 9 females) with a mean age of 57.0±9.7 years were enrolled in the study. Twenty-six (60.5%) eyes were classified as stage 0, 16 (37.2%) eyes as stage 1 and one (2.3%) eye as stage 2 according to Pentacam Nucleus Staging software (PNS) preoperatively. Seven eyes that had PNS stage 0 initially progressed to PNS stage 1 at one month after the injection. The PNS stages of the 36 eyes remained unchanged. The average nucleus density was 9.58±1.12 preoperatively and 9.80± 1.26 one month after injection (p=0.103).

Conclusions:

Lens nucleus densitometry is an objective method for the evaluation of lens clarity. Intravitreal ranibizumab injection seems to cause an increase in the lens nucleus density measurement albeit the difference was not statistically significant. However, further prospective studies are mandatory to establish the long-term effect of intravitreal ranibizumab injection on cataract development process and to ascertain the clinical significance of these changes.

Financial Disclosure:

NONE

Back to Poster listing